Treatment of Pericarditis Pain
Aspirin (750-1000 mg every 8 hours) or ibuprofen (600 mg every 8 hours) combined with colchicine (weight-adjusted dosing) is the recommended first-line treatment for pericarditis pain, with gastroprotection mandatory. 1, 2
First-Line Therapy: NSAIDs Plus Colchicine
NSAIDs are the cornerstone of pain management:
- Aspirin 750-1000 mg every 8 hours OR ibuprofen 600 mg every 8 hours 1, 2
- Treatment duration is typically 1-2 weeks, guided by symptom resolution and C-reactive protein (CRP) normalization 1, 2
- Gastroprotection is mandatory with proton pump inhibitors or H2 blockers 1
- Choose aspirin over other NSAIDs if the patient already requires antiplatelet therapy 1
Colchicine must be added to NSAIDs as first-line therapy:
- Weight-adjusted dosing: 0.5 mg once daily if <70 kg; 0.5 mg twice daily if ≥70 kg 1, 2
- Continue for 3 months to reduce recurrence risk from 37.5% to 16.7% (absolute risk reduction 20.8%) 2, 3
- Colchicine improves symptom relief and prevents recurrences when combined with NSAIDs 1, 2
Tapering Strategy
NSAIDs should be tapered gradually once symptoms resolve and CRP normalizes:
- Aspirin: decrease by 250-500 mg every 1-2 weeks 1
- Ibuprofen: decrease by 200-400 mg every 1-2 weeks 1
- Do not taper until both symptoms are absent AND CRP is normal 1, 2
- Colchicine tapering is not mandatory but can be considered in the final weeks 1
Second-Line Therapy: Corticosteroids
Corticosteroids should only be used when NSAIDs and colchicine fail or are contraindicated:
- Low to moderate doses: prednisone 0.2-0.5 mg/kg/day (NOT high doses of 1.0 mg/kg/day) 1
- Corticosteroids are NOT first-line because they increase risk of chronic evolution, recurrence, and drug dependence 1, 2
- When used, combine with colchicine and taper very slowly after symptom resolution and CRP normalization 1
- The European Society of Cardiology guidelines emphasize corticosteroids as a second option specifically due to these risks 1
Monitoring and Response Assessment
Use CRP to guide treatment duration and assess response:
- CRP should normalize before considering tapering 1, 2
- If no response to NSAIDs within 7 days, this is a poor prognostic factor requiring hospital admission and etiology search 1
- Monitor for recurrence, which occurs in 15-30% of patients despite optimal first-line therapy 2, 3
Activity Restriction
Physical activity must be restricted until complete resolution:
- Restrict activity beyond ordinary sedentary life until symptoms resolve AND CRP, ECG, and echocardiogram normalize 1, 2
- Athletes require minimum 3 months restriction from competitive sports after initial onset 1, 2
- Non-athletes can return to activity once remission is achieved (shorter than 3 months) 1
Critical Pitfalls to Avoid
Inadequate treatment of the first episode is the most common cause of recurrence:
- Never use corticosteroids as first-line therapy unless NSAIDs are contraindicated 1, 2
- Do not taper NSAIDs too rapidly (within 1 month increases recurrence risk) 4
- Do not omit colchicine—it reduces recurrence by approximately 50% 2, 3
- Avoid high-dose corticosteroids (≥1.0 mg/kg/day prednisone), which promote chronicity 1
Risk stratification determines outpatient vs. inpatient management: